Aeglea BioTherapeutics (AGLE) Insider Trading & Ownership → The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad) Free AGLE Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial Media Aeglea BioTherapeutics (NASDAQ:AGLE) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage6.60%Number OfInsiders Buying(Last 3 Years)5Amount OfInsider Buying(Last 3 Years)$1.57 MNumber OfInsiders Selling(Last 3 Years)0 Get AGLE Insider Trade Alerts Want to know when executives and insiders are buying or selling Aeglea BioTherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address AGLE Insider Buying and Selling by Quarter Ad Banyan Hill PublishingREAD THIS – If You Missed Out On The AI BoomAdam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy. Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.”Click on Adam's shiny forehead for more details. Aeglea BioTherapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/25/2022Marcio SouzaDirectorBuy3,600$14.00$50,400.00 6/8/2022Jr. Michael Conick HanleyInsiderBuy1,128$17.75$20,022.00 3/16/2022Anthony G QuinnCEOBuy3,203$58.50$187,375.50 3/14/2022Anthony G QuinnCEOBuy2,698$48.25$130,178.50 3/11/2022Anthony G QuinnCEOBuy1,391$51.50$71,636.50 3/11/2022Jonathan AlspaughCFOBuy3,000$52.00$156,000.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 12/13/2021Armen ShanafeltDirectorBuy587$91.25$53,563.75 12/9/2021Anthony G QuinnCEOBuy1,724$92.50$159,470.00 12/9/2021Armen ShanafeltDirectorBuy4,871$91.75$446,914.25 12/9/2021Jonathan AlspaughCFOBuy2,000$93.00$186,000.00 8/18/2021Jonathan AlspaughCFOBuy288$168.00$48,384.00 8/16/2021Jonathan AlspaughCFOBuy391$159.25$62,266.75 (Data available from 1/1/2013 forward) AGLE Insider Trading Activity - Frequently Asked Questions Who is on Aeglea BioTherapeutics's Insider Roster? The list of insiders at Aeglea BioTherapeutics includes Anthony G Quinn, Armen Shanafelt, Jonathan Alspaugh, Jr. Michael Conick Hanley, and Marcio Souza. Learn more on insiders at AGLE. What percentage of Aeglea BioTherapeutics stock is owned by insiders? 6.60% of Aeglea BioTherapeutics stock is owned by insiders. Learn more on AGLE's insider holdings. Which Aeglea BioTherapeutics insiders have been buying company stock? The following insiders have purchased AGLE shares in the last 24 months: Jr. Michael Conick Hanley ($20,022.00), and Marcio Souza ($50,400.00). How much insider buying is happening at Aeglea BioTherapeutics? Insiders have purchased a total of 4,728 AGLE shares in the last 24 months for a total of $70,422.00 bought. More Insider Trading Tools from MarketBeat Related Companies: CalciMedica Insider Ownership Immuneering Insider Ownership Jaguar Health Insider Ownership Checkpoint Therapeutics Insider Ownership Nabriva Therapeutics Insider Ownership Aadi Bioscience Insider Ownership Eledon Pharmaceuticals Insider Ownership Clene Insider Ownership Homology Medicines Insider Ownership Bolt Biotherapeutics Insider Ownership Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: The 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1 This page (NASDAQ:AGLE) was last updated on 5/1/2024 by MarketBeat.com Staff From Our Partners😱 This phenomenon is smashing regular market gainsMillPub#1 election stockPorter & CompanyBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingBiden out June 13; Kamala won’t replace him?Paradigm Press4 coins to be the “Next Bitcoin”True Market InsidersThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aeglea BioTherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
